chr3-123102794-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_006810.4(PDIA5):āc.385A>Gā(p.Lys129Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000698 in 1,605,540 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000099 ( 0 hom., cov: 35)
Exomes š: 0.000067 ( 0 hom. )
Consequence
PDIA5
NM_006810.4 missense, splice_region
NM_006810.4 missense, splice_region
Scores
1
9
9
Splicing: ADA: 0.08831
2
Clinical Significance
Conservation
PhyloP100: 6.64
Genes affected
PDIA5 (HGNC:24811): (protein disulfide isomerase family A member 5) This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal ER-signal sequence, three catalytically active thioredoxin (TRX) domains, a TRX-like domain, and a C-terminal ER-retention sequence. The N-terminal TRX-like domain is the primary binding site for the major ER chaperone calreticulin and possibly other proteins and substrates as well. Alternative splicing results in multiple protein- and non-protein-coding transcript variants. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.052443206).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PDIA5 | NM_006810.4 | c.385A>G | p.Lys129Glu | missense_variant, splice_region_variant | 5/17 | ENST00000316218.12 | |
PDIA5 | NR_028444.2 | n.525A>G | splice_region_variant, non_coding_transcript_exon_variant | 5/16 | |||
PDIA5 | XR_007095629.1 | n.525A>G | splice_region_variant, non_coding_transcript_exon_variant | 5/14 | |||
PDIA5 | XR_007095630.1 | n.525A>G | splice_region_variant, non_coding_transcript_exon_variant | 5/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PDIA5 | ENST00000316218.12 | c.385A>G | p.Lys129Glu | missense_variant, splice_region_variant | 5/17 | 1 | NM_006810.4 | P1 | |
PDIA5 | ENST00000489923.5 | c.385A>G | p.Lys129Glu | missense_variant, splice_region_variant, NMD_transcript_variant | 5/16 | 1 | |||
PDIA5 | ENST00000484644.5 | c.97A>G | p.Lys33Glu | missense_variant, splice_region_variant | 5/6 | 5 | |||
PDIA5 | ENST00000495004.1 | n.404A>G | splice_region_variant, non_coding_transcript_exon_variant | 4/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152264Hom.: 0 Cov.: 35
GnomAD3 genomes
AF:
AC:
15
AN:
152264
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251240Hom.: 0 AF XY: 0.000140 AC XY: 19AN XY: 135808
GnomAD3 exomes
AF:
AC:
35
AN:
251240
Hom.:
AF XY:
AC XY:
19
AN XY:
135808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000667 AC: 97AN: 1453276Hom.: 0 Cov.: 29 AF XY: 0.0000677 AC XY: 49AN XY: 723706
GnomAD4 exome
AF:
AC:
97
AN:
1453276
Hom.:
Cov.:
29
AF XY:
AC XY:
49
AN XY:
723706
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152264Hom.: 0 Cov.: 35 AF XY: 0.0000672 AC XY: 5AN XY: 74394
GnomAD4 genome
AF:
AC:
15
AN:
152264
Hom.:
Cov.:
35
AF XY:
AC XY:
5
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
12
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.385A>G (p.K129E) alteration is located in exon 5 (coding exon 5) of the PDIA5 gene. This alteration results from a A to G substitution at nucleotide position 385, causing the lysine (K) at amino acid position 129 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;D
Polyphen
P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at